Morgan Stanley Wants In on the Bitcoin and Solana ETF Game
The investment bank has submitted applications to the SEC for the new funds. This follows the massive success of spot Bitcoin ETFs, which now hold over $120 billion in assets.
The investment bank has submitted applications to the SEC for the new funds. This follows the massive success of spot Bitcoin ETFs, which now hold over $120 billion in assets.
Meta is rolling out two major new features for its Ray-Ban Display smart glasses. Users will be able to text by writing with their hand in the air and use a teleprompter for notes.
In a massive bet on the AI boom’s energy appetite, power generation giant Vistra is buying Cogentrix Energy for $4.7 billion. The deal adds ten natural gas plants across key U.S. grids to directly serve exploding data center demand.
Samsung SDS is building a major new data center in Gumi, South Korea, with a $295 million initial investment. The facility, set to open by 2029, is part of Samsung’s broader $308 billion domestic AI and semiconductor push.
Tesla’s stock remains near record highs despite losing its crown as the world’s top EV seller to China’s BYD. Investors are betting on Elon Musk’s promises of autonomous robotaxis and humanoid robots, but detailed data on these futuristic projects is scarce.
You won’t find a flashy new Linux desktop at CES, but the open-source OS is the foundational layer for everything from $3,999 AI workstations to software-defined cars. Canonical is leading the charge, helping manufacturers comply with the EU’s upcoming Cyber Resilience Act. The show proves Linux’s f
Despite President Trump’s push for U.S. oil companies to “go in so badly” to Venezuela, the industry is hitting the brakes. Rebuilding the decimated sector could take until 2030 and cost $110 billion, and companies want stability before risking capital.
HP is reviving the keyboard computer with its new EliteBoard G1a. It packs Ryzen AI processors, up to 64GB of RAM, and 2TB of storage into a desktop keyboard. This “Next Gen AI PC” is aimed at commercial users but could hint at a broader comeback.